Discovery

Systematic, data-driven science coverage · Thursday, July 30, 2026
More from Discovery
Novoron Bio's Alzheimer's tau screening platform supported by NIH monies
Discovery

Novoron Bio's Alzheimer's tau screening platform supported by NIH monies

San Diego-based Novoron Bioscience, Inc. has received a USD 1.25 million NIH R44 SBIR grant from the National Institute on Aging to develop a human...

Jun 10
Icahn School of Medicine at Mount Sinai picks up NIH funding for mRNA-lipid nanoparticle rotator cuff therapy
Discovery

Icahn School of Medicine at Mount Sinai picks up NIH funding for mRNA-lipid nanoparticle rotator cuff therapy

Icahn School of Medicine at Mount Sinai has received a USD 2.06 million NIH R01 grant to develop an mRNA-lipid nanoparticle therapy targeting muscle...

Jun 10
Sur180 Therapeutics gets NIH SBIR grant to advance CRH antagonist for endometriosis
Discovery

Sur180 Therapeutics gets NIH SBIR grant to advance CRH antagonist for endometriosis

Sur180 Therapeutics receives USD 1.14 million NIH SBIR grant to advance CRH antagonist for endometriosis

Jun 10
University of Georgia backed with USD 1.47m NIA award for engineered bacterial Alzheimer's therapeutic
Discovery

University of Georgia backed with USD 1.47m NIA award for engineered bacterial Alzheimer's therapeutic

The University of Georgia has received a USD 1.47 million National Institute on Aging U01 continuation award to advance preclinical development of a...

Jun 10
UCSF backed with NIA grant to explore IL-6 signaling, olamkicept in Alzheimer's
Discovery

UCSF backed with NIA grant to explore IL-6 signaling, olamkicept in Alzheimer's

The University of California, San Francisco has received a USD 1.07 million National Institute on Aging R01 award to investigate whether IL-6...

Jun 10
AbVacc receives USD 1m NIH award for Marburg antibody cocktail advancement
Discovery

AbVacc receives USD 1m NIH award for Marburg antibody cocktail advancement

NIH backs Marburg antibody cocktail in continued SBIR support for AbVacc

Jun 9
Yale University secures USD 3.3m NIH grant for NgR1 inhibitor in spinal cord injury trial
Discovery

Yale University secures USD 3.3m NIH grant for NgR1 inhibitor in spinal cord injury trial

Yale University has received a USD 3.3 million NIH UG3 grant to advance a Phase II clinical trial of AXER-204, a Nogo-66 Receptor 1 (NgR1) pathway...

Jun 4
Weill Cornell Medical College receives USD 3.6m NIH grant for tuberculosis treatment duration research
Discovery

Weill Cornell Medical College receives USD 3.6m NIH grant for tuberculosis treatment duration research

Weill Cornell Medical College has received a USD 3.6 million NIH Program Project grant to investigate the microbial determinants of tuberculosis treatment...

Jun 4
The AllSci BriefSystematic R&D and deal news. Daily.
Lysoway Therapeutics secures USD 3.4m Michael J. Fox Foundation grant for TMEM175 Parkinson's program
Discovery

Lysoway Therapeutics secures USD 3.4m Michael J. Fox Foundation grant for TMEM175 Parkinson's program

Lysoway Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company focused on lysosomal ion channel modulators, has received approximately USD...

Jun 3
Mayo Clinic Jacksonville backed with USD 1.87m NIH grant for PINK1 kinase Parkinson's research
Discovery

Mayo Clinic Jacksonville backed with USD 1.87m NIH grant for PINK1 kinase Parkinson's research

Mayo Clinic Jacksonville has received a USD 1.87 million NIH RF1 grant from the National Institute of Neurological Disorders and Stroke to investigate...

May 29
Discovery

Duke University receives USD 1.81m NIH grant for LRRK2 kinase biomarker research in neurodegeneration

Duke University has received a USD 1.81 million NIH RF1 grant from the National Institute of Neurological Disorders and Stroke to investigate how LRRK2...

May 21
Discovery

University of Georgia receives USD 1.3m NIH grant for Parkinson's disease neuroinflammation research

University of Georgia has received a USD 1.3 million NIH RF1 grant from the National Institute of Neurological Disorders and Stroke to investigate...

May 21
Discovery

Hyundai Bio claims niclosamide offers hope of treating Ebola, hantavirus in preclinical assays

Hyundai Bioscience reported an Ebola virus IC50 of 0.125 μM for its broad-spectrum antiviral candidate XAFTY (niclosamide), according to a company press...

May 21
Discovery

Gladstone Institutes receives USD 2m NIAID award for AI-guided phage therapy development

Gladstone Institutes has received a USD 2 million NIAID P01 award to establish the PhAIge Therapy Center, a multi-project preclinical program applying...

May 20
Discovery

UCSD receives USD 2.5m NIDA grant for Brain-FRAMe HIV research program

University of California, San Diego has received a USD 2.5 million RM1 grant from the National Institute on Drug Abuse to launch Brain-FRAMe, a...

May 20